Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy

BACKGROUND: Ofatumumab, a fully humanized anti-CD20 monoclonal antibody, has shown promising efficacy in limited cases of neuromyelitis optica spectrum disorder, but there is a lack of studies on its use in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. We present a case of refrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Shugang, Du, Jing, Pan, Sidi, Zhang, Juanjuan, Xu, Si, Wei, Ling, Tian, Yanghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200986/
https://www.ncbi.nlm.nih.gov/pubmed/37223100
http://dx.doi.org/10.3389/fimmu.2023.1164181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200986/
https://www.ncbi.nlm.nih.gov/pubmed/37223100
http://dx.doi.org/10.3389/fimmu.2023.1164181

Ejemplares similares